Literature DB >> 34743208

Macrophage-mediated RON signaling supports breast cancer growth and progression through modulation of IL-35.

Sasha J Ruiz-Torres1, Jennifer R Bourn1, Nancy M Benight1, Brian G Hunt1, Carissa Lester1, Susan E Waltz2,3.   

Abstract

Tumor associated macrophages (TAMs) play a major role in regulating mammary tumor growth and in directing the responses of tumor infiltrating leukocytes in the microenvironment. However, macrophage-specific mechanisms regulating the interactions of macrophages with tumor cells and other leukocytes that support tumor progression have not been extensively studied. In this study, we show that the activation of the RON receptor tyrosine kinase signaling pathway specifically in macrophages supports breast cancer growth and metastasis. Using clinically relevant murine models of breast cancer, we demonstrate that loss of macrophage RON expression results in decreases in mammary tumor cell proliferation, survival, cancer stem cell self-renewal, and metastasis. Macrophage RON signaling modulates these phenotypes via direct effects on the tumor proper and indirectly by regulating leukocyte recruitment including macrophages, T-cells, and B-cells in the mammary tumor microenvironment. We further show that macrophage RON expression regulates the macrophage secretome including IL-35 and other immunosuppressive factors. Overall, our studies implicate activation of RON signaling in macrophages as a key player in supporting a thriving mammary pro-tumor microenvironment through novel mechanisms including the augmentation of tumor cell properties through IL-35.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34743208      PMCID: PMC8758553          DOI: 10.1038/s41388-021-02091-y

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  50 in total

1.  Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation.

Authors:  Glendon M Zinser; Mike A Leonis; Kenya Toney; Peterson Pathrose; Megan Thobe; Sarah A Kader; Belinda E Peace; Shirelyn R Beauman; Margaret H Collins; Susan E Waltz
Journal:  Cancer Res       Date:  2006-12-15       Impact factor: 12.701

Review 2.  Interleukin-35: Expanding Its Job Profile.

Authors:  Deepali V Sawant; Kristia Hamilton; Dario A A Vignali
Journal:  J Interferon Cytokine Res       Date:  2015-04-28       Impact factor: 2.607

Review 3.  IL-12 family cytokines: immunological playmakers.

Authors:  Dario A A Vignali; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2012-07-19       Impact factor: 25.606

Review 4.  Molecular Pathways: Interleukin-35 in Autoimmunity and Cancer.

Authors:  Yuliya Pylayeva-Gupta
Journal:  Clin Cancer Res       Date:  2016-08-31       Impact factor: 12.531

Review 5.  Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape.

Authors:  Max D Wellenstein; Karin E de Visser
Journal:  Immunity       Date:  2018-03-20       Impact factor: 31.745

6.  Macrophage stimulating protein (MSP) evokes superoxide anion production by human macrophages of different origin.

Authors:  S Brunelleschi; L Penengo; L Lavagno; C Santoro; D Colangelo; I Viano; G Gaudino
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

7.  Ron receptor regulates Kupffer cell-dependent cytokine production and hepatocyte survival following endotoxin exposure in mice.

Authors:  William D Stuart; Rishikesh M Kulkarni; Jerilyn K Gray; Juozas Vasiliauskas; Mike A Leonis; Susan E Waltz
Journal:  Hepatology       Date:  2011-05       Impact factor: 17.425

8.  Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein.

Authors:  Jianguo Liu; Xiuqin Guan; Tomohiko Tamura; Keiko Ozato; Xiaojing Ma
Journal:  J Biol Chem       Date:  2004-10-15       Impact factor: 5.157

9.  The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans.

Authors:  Alana L Welm; Julie B Sneddon; Carmen Taylor; Dimitry S A Nuyten; Marc J van de Vijver; Bruce H Hasegawa; J Michael Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-24       Impact factor: 11.205

10.  Differential regulation of interleukin-12 p40 and p35 induction via Erk mitogen-activated protein kinase-dependent and -independent mechanisms and the implications for bioactive IL-12 and IL-23 responses.

Authors:  Helen S Goodridge; William Harnett; Foo Y Liew; Margaret M Harnett
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

View more
  2 in total

1.  RON (MST1R) and HGFL (MST1) Co-Overexpression Supports Breast Tumorigenesis through Autocrine and Paracrine Cellular Crosstalk.

Authors:  Brian G Hunt; Angelle Jones; Carissa Lester; James C Davis; Nancy M Benight; Susan E Waltz
Journal:  Cancers (Basel)       Date:  2022-05-19       Impact factor: 6.575

Review 2.  Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells.

Authors:  Shahang Luo; Guanghui Yang; Peng Ye; Nengqi Cao; Xiaoxia Chi; Wen-Hao Yang; Xiuwen Yan
Journal:  Biomolecules       Date:  2022-06-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.